The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada

Arik Drucker; C. Skedgel; K. Virik; D. Rayson; M. Sellon; T. Younis

doi:10.3747/co.v15i3.249

The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada

Arik Drucker, C. Skedgel, K. Virik, D. Rayson, M. Sellon, T. Younis

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	21-27
Number of pages	7
Journal	Current Oncology
Volume	15
Issue number	3
DOIs	https://doi.org/10.3747/co.v15i3.249
Publication status	Published - 2008
Externally published	Yes

ASJC Scopus Subject Areas

Oncology

Keywords

Bevacizumab
Health care costs
Monoclonal antibodies
Neoplams
Trastuzumab

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3747/co.v15i3.249

Cite this

@article{37d042a26655486ca49290486ea42e15,

title = "The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada",

keywords = "Bevacizumab, Health care costs, Monoclonal antibodies, Neoplams, Trastuzumab",

author = "Arik Drucker and C. Skedgel and K. Virik and D. Rayson and M. Sellon and T. Younis",

year = "2008",

doi = "10.3747/co.v15i3.249",

language = "English",

volume = "15",

pages = "21--27",

journal = "Current Oncology",

issn = "1198-0052",

publisher = "Multimed Inc.",

number = "3",

}

TY - JOUR

T1 - The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada

AU - Drucker, Arik

AU - Skedgel, C.

AU - Virik, K.

AU - Rayson, D.

AU - Sellon, M.

AU - Younis, T.

PY - 2008

Y1 - 2008

KW - Bevacizumab

KW - Health care costs

KW - Monoclonal antibodies

KW - Neoplams

KW - Trastuzumab

UR - http://www.scopus.com/inward/record.url?scp=54349083317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54349083317&partnerID=8YFLogxK

U2 - 10.3747/co.v15i3.249

DO - 10.3747/co.v15i3.249

M3 - Review article

AN - SCOPUS:54349083317

SN - 1198-0052

VL - 15

SP - 21

EP - 27

JO - Current Oncology

JF - Current Oncology

IS - 3

ER -

The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this